Cancer Screening

Inherited genetic determinants can cause normal variations in PSA levels even in the absence of prostate cancer

Pap and HPV testing together is highly sensitive and offers the most comprehensive defense against rising rates of cervical cancer

A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse

Cancer screening delays need immediate attention to avoid a surge in late-stage diagnoses

New synthetic immunohistochemistry reference standards could enable semiquantitative tumor analysis for emerging immunotherapies

Patients with high levels of PD-L2 may benefit from immunotherapy

Patients who carry certain germline mutations have a twofold increased risk of developing cancer in both breasts

New blood test could lead to more affordable cancer detection at earlier stages

Download this application note to learn how you can leverage functional proteomics to reveal unique multi-omic signatures and insights into oncology

Researchers describe the impact of epigenetics on cancer treatment and early detection